General information about company

Name of The CompanyNatural Capsules Limited
BSE Scrip Code524654
NSE SymbolNA
MSE SymbolNA
Date of Start of Financial Year01-04-2024
Date of End of Financial Year31-03-2025
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2024
Date of End of Reporting Period30-09-2024
Level of rounding to be used in disclosing related party transactionsLakhs
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicYes
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?Yes
Latest Date on which RPT policy is updated21-05-2024
Indicate Company website link for updated RPT policy of the Companywww.naturalcapsules.com






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1Natural Capsules LimitedAAACN6209MSunil Laxminarayana MundraABQPM2191PDirectorRemunerationNo29.103.07Textual Information(1)
2Natural Capsules LimitedAAACN6209MLaxminarayan MoondraADVPM5759JDirectorRemunerationNo19.402.25Textual Information(2)
3Natural Capsules LimitedAAACN6209MSathyanarayana MundraADVPM5763ADirectorRemunerationNo23.350.852.75Textual Information(3)
4Natural Capsules LimitedAAACN6209MSushil Kumar MundraACSPM4710BDirectorAny other transactionSitting feeNo0.300Textual Information(4)
5Natural Capsules LimitedAAACN6209MJyothi MundraAGXPM3106CDirectorAny other transactionSitting feeNo0.7500Textual Information(5)
6Natural Capsules LimitedAAACN6209MR K PrasadAJNPP9480BCFORemunerationNo7.170.170.87Textual Information(6)
7Natural Capsules LimitedAAACN6209MShilpa BurmanCLFPB7203NCSRemunerationNo3.40.450.54Textual Information(7)
8Natural Capsules LimitedAAACN6209MNatural Biogenex Private LimitedAAHCN1098HSubsidiaryInvestmentNo020002000Textual Information(8)
9Natural Capsules LimitedAAACN6209MSonia OrganicsABIFS0783KWholetime Director is a partnerAny other transactionLease Rental10No2.331.160Textual Information(9)
10Natural Capsules LimitedAAACN6209MMM Shankla EnterprisesAAHFM8103FDirector's brother in law is a partnerAny other transactionPurchase of Electrical equipment50No7.693.114.31Textual Information(10)
11Natural Capsules LimitedAAACN6209MBalurghat Technologies LimitedAABCB0443JDirector's son in law is a directorAny other transactionTravel agency related transaction10No000Textual Information(11)
12Natural Capsules LimitedAAACN6209MNatural Phyto Pharma Private LimitedAAGCN2188RSubsidiaryAdvance10No01.020Textual Information(12)
13Natural Capsules LimitedAAACN6209MVivek Ousourcing Services Private LimitedAABCV7834RDirector's son in law is a directorAny other transactionTravel agency related transaction5No0.7100Textual Information(13)
14Natural Capsules LimitedAAACN6209MM/s.Minakshi EnamelsAADFM0101DDirector is a partnerAny other transactionJob Work 5No000Textual Information(14)
15Natural Capsules LimitedAAACN6209MNatural Biogenex Private LimitedAAHCN1098HSubsidiaryLoan5000No2072.742236.754295Textual Information(15)
16Natural Capsules LimitedAAACN6209MShrey Mundra CBHPM1841BManaging Directors SonRemunerationNo10.51.181.24Textual Information(16)
17Natural Biogenex Private LimitedAAHCN1098HSonia OrganicsABIFS0783KDirector is a partnerAny other transactionJob Work50No000Textual Information(17)
18Natural Biogenex Private LimitedAAHCN1098HM M Shankala EnterprisesAAHFM8103FDirector's brother in law is a partnerAny other transactionPurchase of Electrical equipment30No0.217.86Textual Information(18)
19Natural Biogenex Private LimitedAAHCN1098HR K PrasadAJNPP9480BCFORemunerationNo4.770.630.57Textual Information(19)
20Natural Biogenex Private LimitedAAHCN1098HShilpa BurmanCLFPB7203NCSRemunerationNo1.270.130.19Textual Information(20)
Total value of transaction during the reporting period2183.68